Get started
Work

The Hospital Readmissions Reduction Program

Year: 2019
Type: article
DOI: 10.1016/j.jchf.2019.07.012
Authors: Mitchell A. Psotka, Gregg C. Fonarow, Larry A. Allen, Karen E. Joynt Maddox, Mona Fiuzat, Paul Heidenreich, Adrian F. Hernandez, Marvin A. Konstam, Clyde W. Yancy, Christopher M. O'Connor
Institutions: Inova Health System, University of California, Los Angeles, University of Colorado Anschutz, Washington University in St. Louis, Duke University, Duke Medical Center, VA Palo Alto Health Care System, Tufts Medical Center, Northwestern University
Language: English
Open Access status: bronze
Funders: U.S. Department of Health and Human Services, American Heart Association, Boehringer Ingelheim, Abbott Laboratories, Amgen, Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Sanofi, Medtronic, Patient-Centered Outcomes Research Institute, Boston Scientific Corporation, Portola Pharmaceuticals, Cytokinetics, Bayer Fund, MyoKardia, ResMed, Verily Life Sciences, National Institutes of Health, National Heart, Lung, and Blood Institute, Janssen Pharmaceuticals
OpenAlex ID: W2979498043
FWCI: 15.2
Cites: 60
Cited by: 105
Related to: 10